Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Individualised extended half-life factor replacement therapy controls haemostasis in orthopaedic surgery

Today, Sobi™  and Sanofi will present data demonstrating that Elocta® (efmoroctocog alfa) and Alprolix® (eftrenonacog alfa) can provide perioperative haemostatic control across a wide spectrum of major and minor surgeries in subjects of all ages with severe haemophilia A and B respectively. The presentation will take place at the World Federation of Hemophilia’s 16th International Musculoskeletal Congress (MSK) 10-12 May 2019, in Madrid, Spain. One of the major complications for people living with haemophilia is recurrent bleeding into joints and subsequent

MIPS – World's First Safety Helmet With MIPS Brain Protection System Released

The Swedish brain protection brand, MIPS, announces Guardio as its first partner in the industrial safety helmet industry.MIPS, the leading brain protection system company, today announces its partnership with Swedish industrial safety company, Guardio, and the development of the first MIPS BPS-equipped industrial safety helmet, scheduled for release in the month of June. Whilst representing another important step in implementing MIPS’ strategy, the partnership is not expected to have any material impact on Net sales or EBIT for MIPS during 2019. “Part of our strategy is to expand into

New turnkey supplier for award-winning school and treatment group

Advania Sweden is the new IT supplier for the school and treatment group Magelungen. Through collaboration with Advania, Magelungen wants to streamline their way of working, simplify and improve IT support for students and staff, and gain a better oversight of the IT environment. “We need a partner who can grow with us, and we’ve found it in Advania – who are located in all the areas where Magelungen have operations”, says Emil Josefsson, IT Coordinator at Magelungen. Magelungen has a distinct cloud strategy – using virtually no locally-installed software, the group is free

ABB wins major order to transmit wind power from North Sea

Zurich, Switzerland, May 10, 2019 - ABB’s power transmission technology supports Germany’s energy transition to renewables in partnership with Aibel.ABB’s Power Grids business has been awarded a triple digit million-euro order from the Aibel/Keppel FELS consortium, which will design, construct, and build the High Voltage Direct Current (HVDC) transmission system for the offshore wind connection project DolWin5. ABB is the HVDC technology provider. This project will deliver 900 megawatts of zero-carbon electricity – enough to power around 1 million homes - from three wind farms some 100 km

Interim report january-march 2019

· Rental income for the period increased to SEK 1,023 million (706)  · The real letting ratio for housing was 98,9 percent · Net operating income for the period increased to SEK 521 million (317) · Net financial items amounted to a negative SEK 237 million (141) · Profit from property management was SEK 173 million (185) · Changes in values of properties amounted to SEK 1,761 million (817) · Changes in values of derivatives were negative in the amount of SEK 313 million (positive 20) · Profit for the period increased to SEK 1,203 million (884) · Property acquisitions

Interim report januari-march 2019

· Rental income for the period increased to SEK 953 million (628) · The real letting ratio for housing was 98.9% · Net operating income for the period increased to SEK 489 million (269) · Net financial items amounted to a negative SEK 209 million (105) · Profit from property management was SEK 143 million (164) · Changes in values of properties amounted to SEK 1,738 million (661) · Changes in values of derivatives amounted to a negative SEK 313 million(positive 18) · Profit for the period amounted to SEK 1,185 million (763) · Property acquisitions during the period

Jacob Birkeland new Head of Media Relations at Skanska AB

Jacob Birkeland has now taken office as the new Head of Media Relations at Skanska AB. In his role, Jacob will be responsible for the Skanska Group’s media contacts and for coordinating this work across the Group’s ten markets.Jacob was most recently employed at the listed residential developer Bonava, where he led the work on building up the company’s name and reputation among journalists, politicians and other public players in his capacity as the Group Head of Press and Public Affairs. Prior to that, he worked as Manager Public Affairs at Samsung and as Head of Press to the Minister for

Kojamo Plc: Managers' Transactions

Kojamo Plc: Managers' Transactions Kojamo Plc Stock Exchange Release, 10 May 2019 at 10:00 a.m. EET Kojamo Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Mikael Aro Position: Member of the Board/Deputy member (X) Legal person Issuer: Kojamo Oyj LEI: 7437007YPUOQZ8OV1R42 Notification type: INITIAL NOTIFICATION Reference number: 7437007YPUOQZ8OV1R42_20190510083757_4 ____________________________________________ Transaction date: 2019-05-09 Venue: NASDAQ HELSINKI LTD (XHEL)

Invitation to Presentation of SimCorp’s Q1 2019 Interim Report

PRESS RELEASE SimCorp will publish its interim report for Q1 2019 to NASDAQ Copenhagen on Wednesday, May 22, 2019 at around 8:00 am (CEST). SimCorp’s Executive Management Board will present the report at a conference call the same day at 11.00 am (CEST). Please use any of the following phone numbers to dial in to the conference call: From Denmark: +45 3272 8042From USA: +1 631 510 7495From other countries: +44 (0) 2071 928000Pin code to access the call: 3487117 At the end of the presentation there will be a Q&A session.It will

MIPS – Press release from the Annual General Meeting in MIPS AB on May 9, 2019

Adoption of the accounts and discharge from liability  The Meeting adopted the balance sheets and income statement for the parent company and the Group. The Meeting discharged the Board of Directors and the CEO from liability for the fiscal year 2018. Appropriation of result  The Meeting resolved on a dividend of SEK 2.50 per share. The record date for the dividend was decided to be Monday 13 May 2019. The dividend is estimated to be paid out to the shareholders on Thursday 16 May 2019. The Board of Directors and fees  The Meeting resolved in accordance with the nomination

Press release Orezone’s rights issue subscribed to 23.8 MSEK

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SWITZERLAND, SINGAPORE, SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL, BE SUBJECT TO LEGAL RESTRICTIONS OR WOULD REQUIRE REGISTRATION OR OTHER MEASURESThe subscription period for Orezone AB’s (“Orezone” or the “Company”) rights issue of shares with preferential rights to the Company’s shareholders ended on 7 May 2019 and the rights issue was subscribed to 90

HiQ behind service station Shell’s successful app Snarveien

HiQ built the Snarveien app for ST1-owned service station chain Shell. The app makes it easy for Shell’s customers to sign up for and manage their coffee subscriptions.“This is a great project where we help a Nordic company digitalise a previously manual process and add value for all coffee-drinkers in Norway,” says Jukka Rautio, Managing Director of HiQ Finland.In Norway, the service stations’ coffee subscriptions are a common phenomenon that is greatly appreciated by Shell’s customers. By purchasing an annual subscription, you can drink unlimited cups of coffee for a whole year.

Kværner ASA: Acquistion of own shares

10 May 2019 - Kværner ASA has yesterday in connection with the company's incentive programme for employees purchased 208 000 own shares in the open market at an average price of NOK 13.64 per share. Following the transaction, Kværner ASA holds a total of 1 131 221 own shares. For further information about the programme, please see Kvaerner's statement of executive remuneration at: http://www.kvaerner.com/toolsmenu/Investors/Corporate-governance-/Notice-of- Annual-General-Meeting-of-Kvarner-ASA/ 

NeuroVive’s IND for clinical development of NeuroSTAT approved by FDA

Lund, Sweden,10 May 2019, NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that the US Food and Drug Administration, FDA, has approved NeuroVive’s IND (Investigational New Drug) application, enabling clinical studies in the US with the company’s drug candidate NeuroSTAT in development for treatment of moderate to severe traumatic brain injury, TBI.In the US, an FDA approved IND application is needed in order for not yet marketed investigational drugs to be used in clinical studies. The application has to contain detailed information about pharmacology and

SOTKAMO SILVER AB RESOLVED TO DIRECT A SHARE ISSUE OF MAX 4,200,000 SHARES AND AN ISSUE OF CONVERTIBLES WITH A TOTAL NOMINAL AMOUNT OF MAXIMUM OF 15 MSEK, RAISING THE PROCEEDS OF MAXIMUM 29.4 MSEK

Press release in Stockholm 10.5.2019, 8.30 o'clock. Share issue: The Board of Directors of Sotkamo Silver AB (publ) (the “Company”) has on this day resolved, under an authorization granted by the Annual General Meeting on 11 April 2019, on a directed share issue of maximum of 4,200,000 shares for a subscription price of SEK 3.60 per share. The right to subscribe for the shares shall, with derogation from the shareholders’ pre-emption rights, vest in a limited number of professional investors that have declared an interest in subscribing for shares. Subscription of shares shall

2cureX invites to an investor meeting in Stockholm on May 15th, 2019

2cureX AB ("2cureX") hereby invites shareholders and the public to attend an investor meeting in Stockholm. The company will present the ongoing operations, the way forward for 2cureX and the offer for the company's ongoing rights issue. The investor meeting is held at Scandic Klara in Stockholm and the entry starts at. 11:30. Lunch and refreshments will be served in conjunction with the investor meeting. The meeting is organised together with OmniCar Holding AB and Sedermera Fondkommission.To attend the investor meeting on May 15th, 2019, please register here:https://sedermera.se/sv/

Alipay and Klarna enable consumers to ‘buy now, pay later’ at AliExpress

AliExpress adds Klarna’s market leading ‘Pay later’ option through world’s leading payment platforms Alipay and AdyenMay 10, 2019 - Three world leading companies in payments, Alipay, Adyen and Klarna, have today announced a partnership to allow shoppers at AliExpress, the global retail online marketplace under Alibaba Group, to use Klarna’s popular ‘Pay later’ solution. Klarna’s ‘Pay later’ solution is enabled by Adyen, the payments provider behind AliExpress. This will empower AliExpress’ shoppers in Germany, the Netherlands, Austria and Finland to decide when and how they want to pay.

Read original

Axactor acquires secured NPL Portfolio in Spain

Madrid, 10th May 2019 Axactor Spain has closed another transaction with a financial institution. The purchase is a secured portfolio with an unpaid balance of approximately 40mEUR, containing 276 claims with more than 300 first charge collaterals. The portfolio represents the first sale of secured credits by this financial institution in the Spanish Market. “Following a long period of focusing on unsecured NPL portfolios, Axactor is very pleased to close this small secured transaction, which originated from the same client as the recent unsecured portfolio closed in April. The

Notice to Annual General Meeting of Endomines AB (publ)

Endomines AB, Stock Exchange Release 10 May 2019 at 08:15 CESTThe shareholders of Endomines AB (publ) are hereby invited to the Annual General Meeting to be held on Monday 10 June at 14.00 CET at Konferens Spårvagnshallarna, Birger Jarlsgatan 57A, 113 56 Stockholm. Attendance, notification etc. To be entitled to participate in the Annual General Meeting, shareholders shall have entered into the share register kept by Euroclear Sweden AB on Monday 3 June 2019, and given notice of his/her intention to participate at the Annual General Meeting no later than Monday 3 June 2019. Notice of

Förändring i OptiFreeze styrelse

Efter diskussion med flertalet huvudägare om bolagets framtida utveckling har Göran Hedbys beslutat att lämna bolagets styrelse och avgå som styrelseordförande. Bolaget kommer inom kort att kalla till extra bolagsstämma. Valberedningen kommer att föreslå Martin Linde till ny styrelseordförande i OptiFreeze. Martin Linde kommer att följa bolaget på nära håll fram till extra bolagsstämman.  Martin har lång erfarenhet som investerare och som VD för flera framgångsrika bolag. Styrelsen kommer fram till extra bolagsstämman att ledas av styrelseledamot Petr Dejmek som träder in i rollen som tf.

I-Tech AB (publ) Interim report Q1 2019

Mölndal, May 10, 2019 - I-Tech AB (publ) (ticker ITECH) publish the interim report for the first quarter 2019.Summary of the period - Q1 2019 ”Continued healthy growth and increased activity with potential new customers” Net turnover for the period amounted to kSEK 6 170 (3 813), which corresponds to an increase in turnover of 62% (2 663%). Operating profit/loss amounted to kSEK -4 435 (-3 295). January to March 2019 · No important events during the period. Important events after the period · The Swedbank Robur Teknik and Microcap funds have increased their

Pooled analyses of the roxadustat global Phase III

This announcement contains inside information 10 May 2019 07:00 BST Pooled analyses of the roxadustat global Phase IIIprogramme confirmed cardiovascular safety Cardiovascular safety endpoints evaluated across CKD patientsnot on dialysis, on incident dialysis and on stable dialysis Better outcome vs. epoetin alfa in incident-dialysis patientsand comparable to placebo in patients not on dialysis AstraZeneca today announced top-line results from the pooled cardiovascular (CV) safety analyses of the global Phase III programme for roxadustat, a first-in-class hypoxia-

Polygon AB (publ) - Interim report 1 January - 31 March 2019

A good start to the yearFIRST QUARTER 2019 · Sales grew 7.9% to EUR 160.0 million. Organic growth amounted to 3.6% and acquired growth contributed another 4.2%. · Adjusted EBITA amounted to EUR 10.0 million, an increase of 2% compared to last year. This slower profit growth reflects planned investments in the organisation to secure future organic growth. · As of 1 March, Polygon acquired Alvisa Holding AG (Alvisa24) in Switzerland with yearly sales of EUR 11 million. · Lars Blecko was elected as a new member of the Board of Directors. Lucas Hendriks, Lars-Ove Håkansson and Ole

There are no items matching the current filter
There are no more items matching the current filter
Back to top